News

The company’s debt profile remains heavy: net debt is about $6.5 billion against a market capitalization of roughly $3 billion, and its enterprise‑value‑to‑free‑cash‑flow ratio is 55×. Following the earnings release, the share price fell 13.5–15 % in morning trade.

Full article

Segment results were mixed: the Americas operating income fell due to non‑recurrent insurance recoveries and the sale of the Chemical business, whereas the Europe, Middle East and Africa region saw a 4.9 % operating‑income rise thanks to favorable price‑mix and currency actions. Operating margin improved to 6.6 % from 5.3 % in Q4 2024, and the free...

Full article

Goodyear reported fourth‑quarter 2025 revenue of $4.92 billion, a 0.6 % year‑over‑year decline but 1.3 % above analyst expectations. Adjusted earnings per share were $0.39 (or $0.36 GAAP), missing the consensus estimate of $0.45 (or $0.61) and leaving the EPS unchanged from the same period a year earlier. Net income for the quarter was $105 million...

Full article

Benchmark’s new Buy rating focuses on the company’s ethanol segment, which is gaining momentum as agribusiness headwinds ease. The rating notes that ANDE’s long‑term growth plan targets earnings per share of US$7.00 by 2028, a 36 % compounded annual growth rate from 2026 onward. To support this trajectory, the firm is investing US$60 million in a c...

Full article

The Andersons, Inc. (NASDAQ:ANDE) is currently trading at an all‑time high, yet a 2‑Stage Free Cash Flow to Equity model values the stock at US$58.70, below the market price of US$65.77. The model, using a 7.6% cost of equity, estimates the company’s total equity at US$2.0 billion, implying a fair P/E of 12.9. Analysts note that the Bloomberg‑style...

Full article

BioGaia AB (publ) is a Swedish healthcare company focused on probiotic products for gut, oral, and immune health, with a market capitalization of approximately SEK 11.05 billion. Its 2023 revenue came largely from the Pediatrics segment, which generated SEK 1.09 billion. Despite a 6.2 % dip in earnings last year, the company projects an annual earn...

Full article

PSP Swiss Property (VTX:PSPN) is heavily weighted by institutional investors, who hold about 51% of the company’s shares, making the stock price sensitive to their trading actions. The largest institutional shareholder is UBS Asset Management AG with roughly 15% of outstanding shares. Insider ownership is minimal, at less than 1%, while the general...

Full article

Shield Therapeutics PLC (AIM:STX) saw its shares rise to 10.14p, a 5 % increase, after the U.S. FDA granted an additional three‑year extension of data exclusivity for its flagship product Accrufer. The new protection, effective until December 19 2028, augments existing patent coverage that extends into the mid‑2030s, thereby extending the company’s...

Full article

Executive turnover adds further risk. Kyndryl’s chief financial officer and general counsel have departed, and the company is under SEC review, delaying its 10‑Q filing and prompting a review of its adjusted free‑cash‑flow metric. CEO Martin J. Schroeter cautions that achieving FY 28 multi‑year targets will be challenging amid softness in bookings...

Full article

Despite the setbacks, valuation models still suggest upside potential. A discounted‑cash‑flow intrinsic value of $83.21 per share is 71.8 % above the current $23.49 price, and the projected P/E of 13.16x is below industry and peer averages. Analysts’ fair‑value estimates average $37.60, indicating a significant upside if the firm can leverage its A...

Full article